These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 204609

  • 1. In vitro studies on splenocyte cytotoxicity against syngeneic mammary carcinomas of mice. 1. Reactivity of splenocytes from mice bearing mammary tumors against the corresponding and against other neoplasms.
    More R, Yron I, Weiss DW.
    Isr J Med Sci; 1978 Jan; 14(1):146-61. PubMed ID: 204609
    [No Abstract] [Full Text] [Related]

  • 2. In vitro detection of immune responses to MTV-induced mammary tumors: activity of spleen cell preparations from both MTV-free and MTV-infected mice.
    Blair PB, Lane MA, Yagi MJ.
    J Immunol; 1974 Feb; 112(2):693-705. PubMed ID: 4360546
    [No Abstract] [Full Text] [Related]

  • 3. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM, Sigel MM, Charyulu VL.
    J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
    [Abstract] [Full Text] [Related]

  • 4. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
    Lopez DM, Lopez PF, Parks WP, Paul RD.
    J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
    [Abstract] [Full Text] [Related]

  • 5. [Increased immunologic reactivity against hepatoma 22A cells in MTV-infected C3H mice in comparison to MTV-free mice].
    Lavrovskiĭ VA, Viksler VKh.
    Biull Eksp Biol Med; 1980 Oct; 90(10):467-9. PubMed ID: 6252986
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the effector cells mediating an "innocent bystander" cytotoxicity reaction induced by a syngeneic mammary adenocarcinoma in mice.
    Paul RD, Padmanabhan R, Lopez DM.
    Cancer Res; 1984 Oct; 44(10):4480-6. PubMed ID: 6467207
    [Abstract] [Full Text] [Related]

  • 7. In vitro detection of immune responses to MTV-induced mammary tumors: qualitative differences in response detected by time studies.
    Blair PB, Lane MA.
    J Immunol; 1975 Jan; 114(1 Pt 1):17-23. PubMed ID: 163276
    [Abstract] [Full Text] [Related]

  • 8. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice.
    Lavrovsky VA, Viksler VK.
    Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791
    [Abstract] [Full Text] [Related]

  • 9. Acquired immunological tolerance and carcinogenesis by the mammary tumor virus. II. Immune responses influencing growth of spontaneous mammary adenocarcinomas.
    Morton DL, Goldman L, Wood DA.
    J Natl Cancer Inst; 1969 Feb; 42(2):321-9. PubMed ID: 4303884
    [No Abstract] [Full Text] [Related]

  • 10. Subset of spleen lymphocytes from BALB/cCrgl mice stimulated by mouse mammary tumor virus.
    Lopez DM, Charyulu V, Sigel MM.
    Cancer Res; 1981 Mar; 41(3):813-8. PubMed ID: 6257384
    [Abstract] [Full Text] [Related]

  • 11. Complexity of factors in sera of different mice that affect MTV-induced mammary tumor cells.
    Blair PB, Lane MA, Mar P.
    J Immunol; 1976 Mar; 116(3):610-4. PubMed ID: 176267
    [Abstract] [Full Text] [Related]

  • 12. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L, Fuji H.
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [Abstract] [Full Text] [Related]

  • 13. Acquired immunological tolerance and carcinogenesis by the mammary tumor virus. I. Influence of neonatal infection with the mammary tumor virus on the growth of spontaneous mammary adenocarcinomas.
    Morton DL.
    J Natl Cancer Inst; 1969 Feb; 42(2):311-20. PubMed ID: 4303883
    [No Abstract] [Full Text] [Related]

  • 14. [Immunologic cross reactions between virus producing and non-virus producing murine mammary carcinoma].
    Zotter S, Kemmer C, Müller M, Micheel B.
    Arch Geschwulstforsch; 1972 Feb; 40(1):23-34. PubMed ID: 4347235
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of in situ and peripheral host immunity to syngeneic tumours employing the multicellular spheroid model.
    Lord EM.
    Br J Cancer Suppl; 1980 Apr; 4():123-7. PubMed ID: 6932915
    [Abstract] [Full Text] [Related]

  • 16. Role of H-2 histocompatibility on generation of cell-mediated cytotoxicity against virus-induced mammary tumors in C3H mice.
    Stutman O.
    Transplant Proc; 1977 Mar; 9(1):1153-5. PubMed ID: 194369
    [No Abstract] [Full Text] [Related]

  • 17. In situ lymphoid cells of mouse mammary tumors. IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor-sensitized mice.
    Ruppert B, Blazar B, Medina D, Heppner G.
    J Immunol; 1979 Jun; 122(6):2180-3. PubMed ID: 448122
    [Abstract] [Full Text] [Related]

  • 18. Nonvirus-associated antigens in virus-induced mouse mammary tumors.
    Vaage J.
    Cancer Res; 1968 Dec; 28(12):2477-83. PubMed ID: 4302532
    [No Abstract] [Full Text] [Related]

  • 19. Naturally occurring lymphocyte reactivity to purified mammary tumor virus antigens.
    Gillette RW, Lowery LT.
    J Reticuloendothel Soc; 1977 Jan; 21(1):1-6. PubMed ID: 191607
    [No Abstract] [Full Text] [Related]

  • 20. Immunology of spontaneous mammary carcinomas in mice: immunogenicity of mammary tumor virus-contaning tissues in mammary tumor virus-free C3H-2 hosts.
    Lavrin DH.
    Cancer Res; 1970 Apr; 30(4):1156-62. PubMed ID: 4323351
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.